Animal models of cognitive function

Area of Science:

• Neuroscience
• Pharmacology
• Translational Medicine

Background:

• Animal models are crucial for understanding cognitive function and developing treatments.
• Basic research models have elucidated neural circuits and molecular events in learning and memory.
• Existing drug-screening models have shown limited success in identifying effective cognitive enhancers.

Purpose of the Study:

• To review animal model systems for cognitive research.
• To extensively evaluate models used for screening drugs, especially those mimicking Alzheimer's disease (AD) cholinergic hypofunction.
• To analyze the utility of these models and reasons for clinical trial failures.

Main Methods:

• Review of established animal models for basic cognitive research (lesion, simple systems).
• Detailed examination of drug-screening models, with a focus on AD-relevant models.
• Evaluation of model efficacy and comparison of preclinical findings with clinical outcomes.

Main Results:

• Basic research models have successfully identified neural correlates of cognition.
• Drug-screening models have identified potential cognition enhancers, but most failed in clinical studies.
• Discrepancies between preclinical drug efficacy and clinical outcomes are a significant challenge.

Conclusions:

• While animal models are valuable for basic neuroscience, their predictive validity for drug development, particularly for AD, is limited.
• Further refinement of models, especially those targeting cholinergic deficits, is needed.
• Understanding the reasons for preclinical-clinical translation failures is critical for future therapeutic development.